Bath & Body Works (NYSE:BBWI – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.48 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.13, MarketWatch Earnings reports. The firm had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.56 billion. Bath & Body Works had a net margin of 9.90% and a negative return on equity of 32.64%. The firm’s quarterly revenue was down 2.6% on a year-over-year basis. During the same quarter last year, the company posted $0.40 EPS. Bath & Body Works updated its FY 2023 guidance to $2.90-$3.10 EPS and its Q4 guidance to $1.70-1.90 EPS.
Bath & Body Works Price Performance
Shares of NYSE:BBWI opened at $29.36 on Friday. The company’s fifty day moving average price is $32.00 and its 200 day moving average price is $35.23. Bath & Body Works has a 12 month low of $27.30 and a 12 month high of $49.55. The firm has a market capitalization of $6.68 billion, a P/E ratio of 9.20, a P/E/G ratio of 1.04 and a beta of 1.84.
Bath & Body Works Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, December 1st. Investors of record on Friday, November 17th will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Thursday, November 16th. This represents a $0.80 annualized dividend and a yield of 2.72%. Bath & Body Works’s dividend payout ratio is currently 25.08%.
Institutional Investors Weigh In On Bath & Body Works
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on the stock. Telsey Advisory Group lowered their price objective on shares of Bath & Body Works from $52.00 to $42.00 and set an “outperform” rating for the company in a research report on Friday. UBS Group raised their price target on shares of Bath & Body Works from $38.00 to $39.00 and gave the company a “neutral” rating in a research report on Thursday, August 24th. Barclays raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $41.00 to $45.00 in a research report on Tuesday, August 1st. JPMorgan Chase & Co. cut shares of Bath & Body Works from a “neutral” rating to an “underweight” rating and decreased their price target for the company from $41.00 to $27.00 in a research report on Tuesday, October 24th. Finally, Citigroup raised their price target on shares of Bath & Body Works from $38.00 to $40.00 and gave the company a “neutral” rating in a research report on Wednesday, August 16th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $41.73.
About Bath & Body Works
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
- Five stocks we like better than Bath & Body Works
- What is Forex and How Does it Work?
- MarketBeat Week in Review – 11/13 – 11/17
- What is the FTSE 100 index?
- 3 large caps with red hot RSIs with upside
- Short Selling: How to Short a Stock
- Johnson Controls International: Nothing but upside for investors
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.